Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
TORONTO, Nov. 13, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company“) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) under the […]
FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) CEO Interview with Dr. Raza Bokhari. FSD Pharma is building the worlds largest licensed indoor cannabis growing facility […]
Social Life Network, Inc. (WDLF) CEO Ken Tapp outlines his vision of WDLF “becoming a billion dollar market cap” company, as it builds out network of niche […]
MYM Nutraceuticals, Inc. (CSE: MYM) (OTC: MYMMF) CEO Interview with Rob Gietl, discussing progress toward the company’s goal of becoming a vertically integrated player in the medicinal cannabis space, with a […]
Nigam Arora: The Coming “Canadian Marijuana Stocks Massacre”. Nigam discusses his long term outlook for cannabis stocks… He expects cannabis stocks focused on the Canadian market to lose 90% value, as market realities set in. […]
Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative. Investor Presentation Deck
Helix TCS (OTC: HLIX) CEO Zachary Venegas talks cannabis industry M&A in technology and security services.
Trulieve Cannabis (OTC: TCNNF) Largest Medical Cannabis Co. In Florida with 80,000 patients. CEO Interview with Kim Rivers
Constellation Brands Inc. (NYSE: STZ) CEO Robert Sands, discusses continued market penetration of the company’s Mexican beer brands, Pacifico, Victoria in US, and global cannabis strategy, including potential of CBD beverages, and Canopy Growth (NYSE: […]
Tilray Inc, (NASDAQ: TLRY) “Global Cannabis Player” Interview with CEO Brendan Kennedy Kennedy, discusses the medical cannabis market and expectation that more countries will be legalizing cannabis for recreational use over next 12-24 months.
Cannabinoids to Treat Serious Neurological and Inflammatory Conditions
The Green Organic Dutchman (TSX: TGOD) Investor Presentation
TORONTO, May 02, 2018 — The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) is pleased to announce that it has successfully completed an initial public offering (the “Offering”) of 31,510,000 units (the “Units”) […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
